CNCR vs. FTXH ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to First Trust Nasdaq Pharmaceuticals ETF (FTXH)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$13.56

Average Daily Volume

3,680

Number of Holdings *

67

* may have additional holdings in another (foreign) market
FTXH

First Trust Nasdaq Pharmaceuticals ETF

FTXH Description The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.

Grade (RS Rating)

Last Trade

$28.09

Average Daily Volume

3,198

Number of Holdings *

50

* may have additional holdings in another (foreign) market
Performance
Period CNCR FTXH
30 Days -8.93% -0.59%
60 Days -10.14% -3.12%
90 Days -9.48% -3.96%
12 Months 29.20% 16.01%
7 Overlapping Holdings
Symbol Grade Weight in CNCR Weight in FTXH Overlap
ACLX C 1.73% 0.73% 0.73%
BMY B 1.72% 8.89% 1.72%
BPMC C 1.58% 0.53% 0.53%
EXEL B 1.9% 1.12% 1.12%
KYMR D 1.32% 0.5% 0.5%
MRK F 1.24% 6.31% 1.24%
REGN F 1.0% 2.51% 1.0%
CNCR Overweight 60 Positions Relative to FTXH
Symbol Grade Weight
GLUE C 2.03%
RVMD C 1.84%
ELVN D 1.68%
XNCR B 1.66%
MRSN D 1.62%
KPTI C 1.57%
REPL B 1.56%
GNLX F 1.56%
MGNX F 1.55%
HCM D 1.54%
SWTX C 1.47%
CRBU F 1.47%
JANX C 1.46%
ERAS C 1.46%
DAWN F 1.44%
IMCR D 1.42%
RXRX F 1.39%
SDGR C 1.39%
ARVN D 1.39%
AURA D 1.38%
LYEL F 1.35%
SNDX F 1.34%
MRUS F 1.33%
RPTX F 1.32%
GERN D 1.31%
IOVA F 1.3%
RCUS F 1.29%
NRIX D 1.29%
FHTX D 1.26%
NUVB C 1.26%
BNTX D 1.25%
ZNTL F 1.25%
BCYC F 1.24%
YMAB F 1.24%
BMEA F 1.22%
PGEN F 1.2%
CGEM F 1.2%
ALLO F 1.18%
NUVL D 1.18%
VOR D 1.17%
GMAB F 1.17%
TYRA F 1.16%
KURA F 1.16%
ACRV F 1.15%
AUTL F 1.13%
STRO F 1.12%
LEGN F 1.1%
IDYA F 1.07%
TSVT F 1.06%
ITOS F 0.98%
IPHA F 0.98%
SMMT D 0.97%
ACET F 0.97%
IMRX F 0.95%
IMTX F 0.93%
RLAY F 0.91%
IGMS F 0.88%
RAPT F 0.88%
FATE F 0.87%
PRLD F 0.55%
CNCR Underweight 43 Positions Relative to FTXH
Symbol Grade Weight
JNJ D -6.95%
PFE D -6.81%
ABBV D -6.56%
GILD C -4.43%
CAH B -4.09%
VTRS A -3.97%
UTHR C -3.9%
ZTS D -3.61%
JAZZ B -3.45%
AMGN D -3.37%
LLY F -3.11%
BIIB F -3.06%
CRL C -2.47%
OGN D -2.43%
ELAN D -1.83%
MEDP D -1.79%
NBIX C -1.39%
HALO F -1.19%
ALKS B -1.06%
PBH A -0.98%
PRGO B -0.97%
CORT B -0.82%
PTGX C -0.71%
TGTX B -0.69%
ALNY D -0.65%
ITCI C -0.63%
ADMA B -0.62%
INCY C -0.62%
RNA D -0.6%
AMRX C -0.55%
VCEL B -0.54%
ACAD D -0.54%
VRTX F -0.51%
ROIV C -0.5%
INSM C -0.49%
TWST D -0.48%
KRYS B -0.48%
EXAS D -0.44%
VKTX F -0.44%
BMRN D -0.43%
SRPT D -0.42%
IONS F -0.41%
MYGN F -0.29%
Compare ETFs